Phase 2 of coronavirus disease (COVID-19) and head and neck cancer: An action plan
Oral Dis
.
2022 Apr:28 Suppl 1:970-972.
doi: 10.1111/odi.13576.
Epub 2020 Aug 19.
Authors
Francesca De Felice
1
,
Valentino Valentini
2
,
Marco de Vincentiis
2
,
Carlo Catalano
3
,
Daniela Musio
1
,
Silvia Mezi
4
,
Daniela Messineo
3
,
Cira Rosaria Tiziana Di Gioia
3
,
Gianluca Tenore
2
,
Paolo Priore
2
,
Massimo Ralli
2
,
Francesco Vullo
3
,
Andrea Botticelli
4
,
Edoardo Brauner
2
,
Filippo Giovannetti
2
,
Antonio Greco
2
,
Umberto Romeo
2
,
Paolo Marchetti
4
,
Carlo Della Rocca
5
,
Antonella Polimeni
2
,
Vincenzo Tombolini
1
Affiliations
1
Department of Radiotherapy, Policlinico Umberto I "Sapienza" University of Rome, Rome, Italy.
2
Department of Oral and Maxillo Facial Sciences, Policlinico Umberto I "Sapienza" University of Rome, Rome, Italy.
3
Department of Radiological Sciences, Oncology and Pathology, Policlinico Umberto I "Sapienza" University of Rome, Rome, Italy.
4
Department of Clinical and molecular oncology, Policlinico Umberto I "Sapienza" University of Rome, Rome, Italy.
5
Department of Medico-Surgical Sciences and Biotechnology, Polo Pontino, "Sapienza" University of Rome, Rome, Italy.
PMID:
32930434
DOI:
10.1111/odi.13576
No abstract available
Keywords:
COVID-19; academic; care; head neck cancer; unit.
Publication types
Comment
MeSH terms
COVID-19*
Head and Neck Neoplasms* / therapy
Humans